Davinthra Thillainathan
Stock Analyst at Goldman Sachs
(2.30)
# 3,252
Out of 5,081 analysts
38
Total ratings
43.5%
Success rate
2.4%
Average return
Main Sectors:
Stocks Rated by Davinthra Thillainathan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: SHL Sonic Healthcare Limited | Downgraded: Hold | $32.20 → $19.20 | $19.13 | +0.37% | 2 | Oct 12, 2026 | |
| ASX: RHC Ramsay Health Care Limited | Upgraded: Buy | $54.10 | $55.40 | -2.35% | 5 | Aug 27, 2026 | |
| ASX: ACL Australian Clinical Labs Limited | Downgraded: Sell | $3.30 → $2.08 | $2.96 | -29.73% | 2 | Aug 6, 2026 | |
| ASX: IDX Integral Diagnostics Limited | Upgraded: Hold | $2.10 → $2.15 | $2.12 | +1.42% | 2 | Jun 1, 2026 | |
| ASX: ANN Ansell Limited | Initiated Coverage: Hold | $31.80 | $46.27 | -31.27% | 1 | Apr 7, 2026 | |
| NZE: FPH Fisher & Paykel Healthcare Corporation Limited | Reiterated: Buy | $52.72 → $54.32 | $48.13 | +12.86% | 5 | Feb 23, 2026 | |
| ASX: RMD ResMed Inc. | Reiterated: Buy | $49.30 → $53.20 | $35.63 | +49.31% | 9 | Feb 2, 2026 | |
| ASX: CSL CSL Limited | Reiterated: Buy | $304.60 → $212.10 | $196.22 | +8.09% | 5 | Oct 29, 2025 | |
| ASX: NAN Nanosonics Limited | Initiated Coverage: Buy | $6.97 | $3.12 | n/a | 1 | Sep 25, 2025 | |
| ASX: HLS Healius Limited | Reiterated: Sell | $1.20 → $0.80 | $0.45 | n/a | 2 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $139.49 | n/a | 4 | Jun 14, 2025 |
Sonic Healthcare Limited
Oct 12, 2026
Downgraded: Hold
Price Target: $32.20 → $19.20
Current: $19.13
Upside: +0.37%
Ramsay Health Care Limited
Aug 27, 2026
Upgraded: Buy
Price Target: $54.10
Current: $55.40
Upside: -2.35%
Australian Clinical Labs Limited
Aug 6, 2026
Downgraded: Sell
Price Target: $3.30 → $2.08
Current: $2.96
Upside: -29.73%
Integral Diagnostics Limited
Jun 1, 2026
Upgraded: Hold
Price Target: $2.10 → $2.15
Current: $2.12
Upside: +1.42%
Ansell Limited
Apr 7, 2026
Initiated Coverage: Hold
Price Target: $31.80
Current: $46.27
Upside: -31.27%
Fisher & Paykel Healthcare Corporation Limited
Feb 23, 2026
Reiterated: Buy
Price Target: $52.72 → $54.32
Current: $48.13
Upside: +12.86%
ResMed Inc.
Feb 2, 2026
Reiterated: Buy
Price Target: $49.30 → $53.20
Current: $35.63
Upside: +49.31%
CSL Limited
Oct 29, 2025
Reiterated: Buy
Price Target: $304.60 → $212.10
Current: $196.22
Upside: +8.09%
Nanosonics Limited
Sep 25, 2025
Initiated Coverage: Buy
Price Target: $6.97
Current: $3.12
Upside: n/a
Healius Limited
Aug 12, 2025
Reiterated: Sell
Price Target: $1.20 → $0.80
Current: $0.45
Upside: n/a
Jun 14, 2025
Reiterated: Hold
Price Target: n/a
Current: $139.49
Upside: n/a